Table of Contents for the Digital Edition of Pharmacy & Therapeutics - March 2010 Pharmacy & Therapeutics - March 2010 Editorial Contents Medication Errors Prescription: Washington New Drugs/Drug News/ New Medical Devices Pharmacy Provisions of Health Care Legislation Are Still Viable Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma San Antonio Breast Cancer Symposium and American Society of Clinical Oncology Pharmaceutical Approval Update Optimizing Anemia Management through Medication Reconciliation CE Test and Forms Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) Pharmacy & Therapeutics - March 2010 Pharmacy & Therapeutics - March 2010 - Pharmacy & Therapeutics - March 2010 (Page Cover1) Pharmacy & Therapeutics - March 2010 - Pharmacy & Therapeutics - March 2010 (Page Cover2) Pharmacy & Therapeutics - March 2010 - Editorial (Page A1) Pharmacy & Therapeutics - March 2010 - Editorial (Page A2) Pharmacy & Therapeutics - March 2010 - Editorial (Page 117) Pharmacy & Therapeutics - March 2010 - Contents (Page 118) Pharmacy & Therapeutics - March 2010 - Contents (Page 119) Pharmacy & Therapeutics - March 2010 - Contents (Page 120) Pharmacy & Therapeutics - March 2010 - Contents (Page 121) Pharmacy & Therapeutics - March 2010 - Contents (Page 122) Pharmacy & Therapeutics - March 2010 - Contents (Page 123) Pharmacy & Therapeutics - March 2010 - Contents (Page 124) Pharmacy & Therapeutics - March 2010 - Contents (Page 125) Pharmacy & Therapeutics - March 2010 - Contents (Page 126) Pharmacy & Therapeutics - March 2010 - Medication Errors (Page 127) Pharmacy & Therapeutics - March 2010 - Prescription: Washington (Page 128) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 129) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 130) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 131) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 132) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 133) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 134) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 135) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 136) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 137) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 138) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 139) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 140) Pharmacy & Therapeutics - March 2010 - New Drugs/Drug News/ New Medical Devices (Page 141) Pharmacy & Therapeutics - March 2010 - Pharmacy Provisions of Health Care Legislation Are Still Viable (Page 142) Pharmacy & Therapeutics - March 2010 - Pharmacy Provisions of Health Care Legislation Are Still Viable (Page 143) Pharmacy & Therapeutics - March 2010 - Pharmacy Provisions of Health Care Legislation Are Still Viable (Page 144) Pharmacy & Therapeutics - March 2010 - Pharmacy Provisions of Health Care Legislation Are Still Viable (Page 145) Pharmacy & Therapeutics - March 2010 - Pharmacy Provisions of Health Care Legislation Are Still Viable (Page 146) Pharmacy & Therapeutics - March 2010 - Pharmacy Provisions of Health Care Legislation Are Still Viable (Page 147) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 148) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 149) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 150) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 151) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 152) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 153) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 154) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 155) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 156) Pharmacy & Therapeutics - March 2010 - Impact of Rituximab (Rituxan) on the Treatment Of B-Cell Non-Hodgkin’s Lymphoma (Page 157) Pharmacy & Therapeutics - March 2010 - San Antonio Breast Cancer Symposium and American Society of Clinical Oncology (Page 158) Pharmacy & Therapeutics - March 2010 - San Antonio Breast Cancer Symposium and American Society of Clinical Oncology (Page 159) Pharmacy & Therapeutics - March 2010 - San Antonio Breast Cancer Symposium and American Society of Clinical Oncology (Page 160) Pharmacy & Therapeutics - March 2010 - San Antonio Breast Cancer Symposium and American Society of Clinical Oncology (Page 161) Pharmacy & Therapeutics - March 2010 - Pharmaceutical Approval Update (Page 162) Pharmacy & Therapeutics - March 2010 - Pharmaceutical Approval Update (Page 163) Pharmacy & Therapeutics - March 2010 - Pharmaceutical Approval Update (Page 164) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 165) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 166) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 167) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 168) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 169) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 170) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 171) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 172) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 173) Pharmacy & Therapeutics - March 2010 - Optimizing Anemia Management through Medication Reconciliation (Page 174) Pharmacy & Therapeutics - March 2010 - CE Test and Forms (Page 175) Pharmacy & Therapeutics - March 2010 - CE Test and Forms (Page 176) Pharmacy & Therapeutics - March 2010 - CE Test and Forms (Page 177) Pharmacy & Therapeutics - March 2010 - CE Test and Forms (Page 178) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z-Cov1) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z-Cov2) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z1) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z2) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z3) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z4) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z5) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z6) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z7) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z8) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z9) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z10) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z11) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z12) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z13) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z14) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z15) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z16) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z17) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z18) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z19) Pharmacy & Therapeutics - March 2010 - Product Profiler: Zemaira® (Alpha1-Proteinase Inhibitor [Human]) (Page Z20) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C-Cov1) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C-Cov2) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C1) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C2) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C3) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C4) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C5) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C6) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C7) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C8) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C9) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C10) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C11) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C12) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C13) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C14) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C15) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C16) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C17) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C18) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C19) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C20) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C21) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C22) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C23) Pharmacy & Therapeutics - March 2010 - Product Profiler: Cytogam® (Cytomegalovirus Immune Globulin Intravenous [Human]) (Page C24) http://www.nxtbook.com/nxtbooks/medimedia/pt_201205 http://www.nxtbook.com/nxtbooks/medimedia/pt_dexilantprofiler http://www.nxtbook.com/nxtbooks/medimedia/pt_201204 http://www.nxtbook.com/nxtbooks/medimedia/pt_201203 http://www.nxtbook.com/nxtbooks/medimedia/pt_201202 http://www.nxtbook.com/nxtbooks/medimedia/pt_201201 http://www.nxtbook.com/nxtbooks/medimedia/pt_201112 http://www.nxtbook.com/nxtbooks/medimedia/pt_201111 http://www.nxtbook.com/nxtbooks/medimedia/pt_201110 http://www.nxtbook.com/nxtbooks/medimedia/pt_201109 http://www.nxtbook.com/nxtbooks/medimedia/pt_201108 http://www.nxtbook.com/nxtbooks/medimedia/pt_201107 http://www.nxtbook.com/nxtbooks/medimedia/pt_201106 http://www.nxtbook.com/nxtbooks/medimedia/pt_201105 http://www.nxtbook.com/nxtbooks/medimedia/pt_201104 http://www.nxtbook.com/nxtbooks/medimedia/pt_201103 http://www.nxtbook.com/nxtbooks/medimedia/pt_201102 http://www.nxtbook.com/nxtbooks/medimedia/pt_201101 http://www.nxtbook.com/nxtbooks/medimedia/pt_201012 http://www.nxtbook.com/nxtbooks/medimedia/pt_201011 http://www.nxtbook.com/nxtbooks/medimedia/pt_201010 http://www.nxtbook.com/nxtbooks/medimedia/pt_201009 http://www.nxtbook.com/nxtbooks/medimedia/pt_201008 http://www.nxtbook.com/nxtbooks/medimedia/pt_201007 http://www.nxtbook.com/nxtbooks/medimedia/pt_201006 http://www.nxtbook.com/nxtbooks/medimedia/pt_201005 http://www.nxtbook.com/nxtbooks/medimedia/pt_201004 http://www.nxtbook.com/nxtbooks/medimedia/pt_201003 http://www.nxtbook.com/nxtbooks/medimedia/pt_201002 http://www.nxtbook.com/nxtbooks/medimedia/pt_201001 http://www.nxtbook.com/nxtbooks/medimedia/pt_200912 http://www.nxtbook.com/nxtbooks/medimedia/pt_200911 http://www.nxtbook.com/nxtbooks/medimedia/pt_200910 http://www.nxtbook.com/nxtbooks/medimedia/pt_200909 http://www.nxtbook.com/nxtbooks/medimedia/pt_200908 http://www.nxtbook.com/nxtbooks/medimedia/pt_200907 http://www.nxtbook.com/nxtbooks/medimedia/pt_200906 http://www.nxtbook.com/nxtbooks/medimedia/pt_200905 http://www.nxtbook.com/nxtbooks/medimedia/pt_200904 http://www.nxtbook.com/nxtbooks/medimedia/pt_200903 http://www.nxtbook.com/nxtbooks/medimedia/pt_200902 http://www.nxtbook.com/nxtbooks/medimedia/pt_200901 http://www.nxtbook.com/nxtbooks/medimedia/pt_200812 http://www.nxtbook.com/nxtbooks/medimedia/pt_200811 http://www.nxtbook.com/nxtbooks/medimedia/pt_200810 http://www.nxtbook.com/nxtbooks/medimedia/pt_200809 http://www.nxtbook.com/nxtbooks/medimedia/pt_200808 http://www.nxtbook.com/nxtbooks/medimedia/pt_200807 http://www.nxtbook.com/nxtbooks/medimedia/pt_200806 http://www.nxtbook.com/nxtbooks/medimedia/pt_200805 http://www.nxtbook.com/nxtbooks/medimedia/pt_200804 http://www.nxtbook.com/nxtbooks/medimedia/pt_200803 http://www.nxtbook.com/nxtbooks/medimedia/pt_200802 http://www.nxtbook.com/nxtbooks/medimedia/pt_200801 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.